A study to evaluate whether the allergic sensitization to pegylated interferon-alpha results in drug eruptions in patients with chronic hepatitis C.
Phase of Trial: Phase IV
Latest Information Update: 30 Dec 2015
At a glance
- Drugs Peginterferon alfa-2a (Primary) ; Peginterferon alfa-2b (Primary) ; Ribavirin
- Indications Hepatitis C
- Focus Adverse reactions; Pharmacodynamics; Proof of concept
- 30 Dec 2015 New trial record